Tuesday - February 17, 2026

Acinetobacter Infections Pipeline Expands as 7+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight | Omnix Medical, Roche, Telum Therapeutics, Spero Therapeutics

Acinetobacter Infections – Pipeline Insight, 2026 DelveInsight’s “Acinetobacter Infections – Pipeline Insight, 2026” report provides comprehensive insights about 8+ companies, including Omnix Medical, Roche, Telum Therapeutics, Spero Therapeutics, VenatoRx Pharmaceuticals, ABAC Therapeutics, and others, developing 10+ pipeline drugs in the … Continue reading

Metastatic Prostate Cancer Clinical Trial Pipeline Advances as 80+ Companies Develop 85+ Pipeline Drugs Across Multiple Stages, Finds DelveInsight | Merck, AstraZeneca, Syntrix Pharmaceuticals

Metastatic Prostate Cancer – Pipeline Insight, 2026 DelveInsight’s “Metastatic Prostate Cancer – Pipeline Insight, 2026” report provides comprehensive insights about 80+ companies including AstraZeneca, Arvinas, Daiichi Sankyo, Bristol Myers Squibb, Merck, MacroGenics, Seagen, Taiho Pharmaceutical, Modra Pharmaceuticals, Xencor, Point Biopharma, … Continue reading

MAHA Uncensored: As RFK Jr.’s “Eat Real Food” Movement Captures National Attention, New Documentary Exposes the System Behind America’s Chronic Disease Crisis

Salt Lake City, Utah – As Robert F. Kennedy Jr.’s Make America Healthy Again (MAHA) movement continues to dominate national headlines — from the widely discussed “Eat Real Food” Super Bowl advocacy campaign to renewed scrutiny of ultra-processed food policy … Continue reading

Consumers Shifting Toward Canadian-Made Adaptogenic Sipping Chocolate Over Traditional Hot Chocolate, Noorish Foods Reports

A growing number of Canadians are replacing traditional powdered hot chocolate with adaptogenic sipping chocolate made from ceremonial cacao and functional superfoods. Golden, BC – Across Canada, consumers are increasingly turning away from conventional powdered hot chocolate and toward Canadian-produced … Continue reading

Uveitis Clinical Trial Pipeline Expands as 15+ Companies Advance 15+ Targeted Ocular Inflammation Therapies Toward Market Entry, Finds DelveInsight | Santen, Clearside Biomedical, Tarsier Pharma

Uveitis – Pipeline Insight, 2026 DelveInsight’s “Uveitis – Pipeline Insight, 2026” report provides comprehensive insights about 15+ companies, including Eli Lilly and Company, Santen Inc., Clearside Biomedical, Affibody, Eyevensys, Alcon Research, Panoptes Pharma, Tarsier Pharma, Eye Pharma, Apitope Technology, Mitotech, … Continue reading

Degenerative Disc Disease Clinical Trial Pipeline Strengthens as 15+ Companies Advance 15+ Regenerative and Non‑Surgical Therapies Toward Market Entry, Finds DelveInsight | Spine BioPharma, Biosplice

“Degenerative Disc Disease – Pipeline Insight, 2026 DelveInsight’s “Degenerative Disc Disease – Pipeline Insight, 2026” report provides comprehensive insights about 15+ companies, including include Spine BioPharma, Inc., BioRestorative Therapies, Mesoblast Ltd., Biosplice Therapeutics, Causeway Therapeutics, AnGes Inc., DiscGenics, Kuros Biosciences, … Continue reading

Celiac Disease Clinical Trial Pipeline Gains Momentum as 25+ Companies Advance Novel Therapies Toward Market Entry: DelveInsight | Teva Pharmaceutical Industries, Barinthus Biotherapeutics, Topas

Celiac Disease – Pipeline Insight, 2026 DelveInsight’s “Celiac Disease – Pipeline Insight, 2026” report provides comprehensive insights about 25+ companies, including Teva Pharmaceutical Industries Ltd., Sanofi, Forte Biosciences, Inc., Takeda, Anokion, Entero Therapeutics, Amgen, Topas Therapeutics, Mozart Therapeutics Australia Pty … Continue reading